# Loss of Early Growth Response Protein 1 in the Liver Leads to Hepatic Lipid Accumulation Driven by an Imbalance Between Fatty Acid β-Oxidation and Oxidative Phosphorylation

**Authors:** Cristy R.C. Verzijl, Dicky Struik, Albert Gerding, Roos E. Eilers, Rachel E. Thomas, Mirjam Koster, Miriam Langelaar-Makkinje, Marieke Smit, Nicolette Huijkman, Rick Havinga, Niels Kloosterhuis, Vincent W. Bloks, Justina C. Wolters, Jan Freark de Boer, Bart van de Sluis, Barbara M. Bakker, Johan W. Jonker

PMC · DOI: 10.1016/j.gastha.2026.100881 · Gastro Hep Advances · 2026-01-19

## TL;DR

Deleting a protein called EGR1 in mice livers causes fat buildup by disrupting fatty acid breakdown and energy production.

## Contribution

Shows EGR1 is critical for balancing fatty acid oxidation and mitochondrial respiration in liver cells.

## Key findings

- EGR1-deficient mice had higher liver triglycerides after a high-fat diet.
- EGR1 deficiency reduced maximum oxygen consumption in hepatocytes.
- Lipid accumulation in EGR1-deficient mice was linked to disrupted fatty acid oxidation.

## Abstract

Metabolic-associated fatty liver disease is a worldwide health problem characterized by increased hepatic lipid accumulation, leading to conditions like steatohepatitis, cirrhosis, and liver cancer. Early growth response protein 1 (EGR1) gene encodes an immediate early transcription factor that regulates a wide variety of cellular processes in response to stress and injury. Whole-body Egr1 knockout studies suggest a role for EGR1 in metabolism, affecting insulin sensitivity, energy homeostasis, cholesterol biosynthesis, and circadian rhythm. However, its direct role in hepatic lipid metabolism remains unclear. This study aimed to investigate the function of EGR1 in the adult liver.

Hepatocyte-specific EGR1-deficient male mice were generated using CRISPR/Cas9. Mice were maintained under chow-fed conditions or challenged with a high-fat diet (HFD). Hepatic lipid levels, zonation, and gene expression were analyzed. Oxygen consumption was measured in mouse and human hepatocytes.

After a HFD challenge, hepatic EGR1-deficient mice showed a significant increase in hepatic triglyceride levels. Transcriptome analysis revealed an upregulation of genes related to fatty acid oxidation and downregulation of mitochondrial respiration genes in livers of both chow and HFD hepatic EGR1-deficient mice. Functional analysis showed reduced maximum oxygen consumption in EGR1-deficient mouse and human hepatocytes. Fasting-induced hepatic lipid accumulation indeed indicated reduced fatty acid oxidation efficiency upon ablation of EGR1.

Hepatic EGR1 deficiency significantly alters lipid metabolism and mitochondrial function, indicating a role of EGR1 in regulating the balance between mitochondrial fatty acid β-oxidation and respiration in the liver.

## Linked entities

- **Genes:** EGR1 (early growth response 1) [NCBI Gene 1958], EGR1 (early growth response 1) [NCBI Gene 1958]
- **Proteins:** EGR1 (early growth response 1)
- **Diseases:** cirrhosis (MONDO:0005155), liver cancer (MONDO:0002691)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Acot1 (acyl-CoA thioesterase 1) [NCBI Gene 26897] {aka ACH2, CTE-1, CTE-I, Cte1, D12Ucla1}, Atp5po (ATP synthase peripheral stalk subunit OSCP) [NCBI Gene 28080] {aka ATPO, Atp5o, D12Wsu28e, OSCP}, Cpt1a (carnitine palmitoyltransferase 1a, liver) [NCBI Gene 12894] {aka C730027G07, CPTI, Cpt1}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}, Hmgcr (3-hydroxy-3-methylglutaryl-Coenzyme A reductase) [NCBI Gene 15357] {aka HMG-CoAR, Red}, Fasn (fatty acid synthase) [NCBI Gene 14104] {aka A630082H08Rik, FAS}, Cs (citrate synthase) [NCBI Gene 12974] {aka 2610511A05Rik, 9030605P22Rik, Ahl4, Cis}, Elovl6 (ELOVL fatty acid elongase 6) [NCBI Gene 170439] {aka FAE, LCE}, Abcd3 (ATP-binding cassette, sub-family D member 3) [NCBI Gene 19299] {aka PMP68, PMP70, Pxmp1}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Cidea (cell death-inducing DNA fragmentation factor, alpha subunit-like effector A) [NCBI Gene 12683], Acot3 (acyl-CoA thioesterase 3) [NCBI Gene 171281] {aka PTE-Ia, Pte2a}, Gckr (glucokinase regulatory protein) [NCBI Gene 231103] {aka GKRP}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, Arg1 (arginase, liver) [NCBI Gene 11846] {aka AI, Arg-1, PGIF}, Decr2 (2-4-dienoyl-Coenzyme A reductase 2, peroxisomal) [NCBI Gene 26378], Tomm20 (translocase of outer mitochondrial membrane 20) [NCBI Gene 67952] {aka 1810060K07Rik, Gm19268, MAS20, MOM19, TOM20, mKIAA0016}, Acot4 (acyl-CoA thioesterase 4) [NCBI Gene 171282] {aka B430212I04Rik, PTE-Ib, Pte1b, Pte2b}, Gpd2 (glycerol phosphate dehydrogenase 2, mitochondrial) [NCBI Gene 14571] {aka GPDH, Gdm1, Gpd-m, Gpdh-m, TISP38}, Acaca (acetyl-Coenzyme A carboxylase alpha) [NCBI Gene 107476] {aka A530025K05Rik, Acac, Acc1, Gm738}, Polg (polymerase (DNA directed), gamma) [NCBI Gene 18975] {aka PolgA}, Cd320 (CD320 antigen) [NCBI Gene 54219] {aka 425O18-1, 8D6, D17Ertd716e, NG29, TCblR, VLDL}, Ndufb6 (NADH:ubiquinone oxidoreductase subunit B6) [NCBI Gene 230075] {aka CI-B17, Gm137}, Egr1 (early growth response 1) [NCBI Gene 13653] {aka A530045N19Rik, ETR103, Egr-1, Krox-1, Krox-24, Krox24}, Ndufb9 (NADH:ubiquinone oxidoreductase subunit B9) [NCBI Gene 66218] {aka 1190008J14Rik, CI-B22}, Ndufa11 (NADH:ubiquinone oxidoreductase subunit A11) [NCBI Gene 69875] {aka 2010012C24Rik, B14.7}, Atp5f1a (ATP synthase F1 subunit alpha) [NCBI Gene 11946] {aka Atp5a1, Atpm, D18Ertd206e, Mom2}, Acnat2 (acyl-coenzyme A amino acid N-acyltransferase 2) [NCBI Gene 209186] {aka C730036D15Rik}, Ndufb10 (NADH:ubiquinone oxidoreductase subunit B10) [NCBI Gene 68342] {aka 0610011B04Rik, 22kDa, PDSW}, Pnpla3 (patatin-like phospholipase domain containing 3) [NCBI Gene 116939] {aka Adpn}, EGR1 (early growth response 1) [NCBI Gene 1958] {aka AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268}, Acaa2 (acetyl-CoA acyltransferase 2) [NCBI Gene 52538] {aka 0610011L04Rik, D18Ertd240e}, Acox1 (acyl-Coenzyme A oxidase 1, palmitoyl) [NCBI Gene 11430] {aka AOX, Acox, D130055E20Rik, Paox}, Tm6sf2 (transmembrane 6 superfamily member 2) [NCBI Gene 107770], Acnat1 (acyl-coenzyme A amino acid N-acyltransferase 1) [NCBI Gene 230161], Apob (apolipoprotein B) [NCBI Gene 238055] {aka Apo B-100, apob-100, apob-48}, Scd1 (stearoyl-Coenzyme A desaturase 1) [NCBI Gene 20249] {aka Scd, Scd-1, ab}, Glul (glutamate-ammonia ligase) [NCBI Gene 14645] {aka GS, Glns}, Ndufa2 (NADH:ubiquinone oxidoreductase subunit A2) [NCBI Gene 17991] {aka B8, C1-B8, CI-B8}
- **Diseases:** dislocation (MESH:D004204), hepatocellular carcinoma (MESH:D006528), hepatic lipid accumulation (MESH:D011017), Hepatic Deficiency (MESH:D056486), liver injury (MESH:D017093), type 2 diabetes mellitus (MESH:D003924), mitochondrial defect (MESH:C565376), end-stage liver disease (MESH:D058625), hypoxia (MESH:D000860), metabolic dysregulation (MESH:D021081), metabolic dysfunction (MESH:D008659), overweight (MESH:D050177), Metabolic-associated fatty liver disease (MESH:D005234), bleeding (MESH:D006470), obesity (MESH:D009765), diabetes (MESH:D003920), cirrhotic (MESH:D000094724), Hepatic Deficiency of EGR1 (MESH:D006130), mitochondrial dysfunction (MESH:D028361), steatotic liver disease (MESH:D008107), inflammation (MESH:D007249), cirrhosis (MESH:D005355)
- **Chemicals:** Glucose (MESH:D005947), acetate (MESH:D000085), PBS (MESH:D007854), oleic acid (MESH:D019301), Tween 20 (MESH:D011136), polyvinylidene fluoride (MESH:C024865), NovoRapid (MESH:D061267), acetyl-L-carnitine- (MESH:D000108), H (MESH:D006859), palmitic acid (MESH:D019308), Lipid (MESH:D008055), sterol (MESH:D013261), citrate (MESH:D019343), CO2 (MESH:D002245), C2 (MESH:C023714), glutamine (MESH:D005973), Acylcarnitine (MESH:C116917), CoA (MESH:D003065), carbohydrate (MESH:D002241), Fatty Acid (MESH:D005227), Acyl-CoA (MESH:D000214), glycerol (MESH:D005990), penicillin (MESH:D010406), L-carnitine (MESH:D002331), hematoxylin (MESH:D006416), C16 + C18) acylcarnitines (-), palmitate (MESH:D010168), fluanisone (MESH:C005014), Bile acids (MESH:D001647), H&amp;E (MESH:D006371), GlutaMAX (MESH:C054122), ethanol (MESH:D000431), Cholesterol (MESH:D002784), Blood glucose (MESH:D001786), sodium dodecyl sulfate (MESH:D012967), Nonesterified fatty acids (MESH:D005230), fentanyl (MESH:D005283), acetyl-CoA (MESH:D000105), diazepam (MESH:D003975), C18:0 (MESH:C031183), isoflurane (MESH:D007530), Oil Red O (MESH:C011049), water (MESH:D014867), UK5099 (MESH:C043654), Triglyceride (MESH:D014280), acetonitrile (MESH:C032159), tricarboxylic acid (MESH:D014233), streptomycin (MESH:D013307), polyacrylamide (MESH:C016679), etomoxir (MESH:C054207), Nonidet P-40 (MESH:C010615), ethylenediaminetetraacetic acid (MESH:D004492), nitrogen (MESH:D009584), O2 (MESH:D010100), acetaminophen (MESH:D000082), pyruvate (MESH:D019289), fat (MESH:D005223), paraffin (MESH:D010232), hypnorm (MESH:C001432), NaCl (MESH:D012965)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Adeno-associated virus (species) [taxon 272636]
- **Cell lines:** HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938867/full.md

## Figures

16 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938867/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938867/full.md

---
Source: https://tomesphere.com/paper/PMC12938867